Search

everythinglearnresearchcommunity

for

Search:↓

Unapproved stem cell therapies are marketed online in the UK, raising safety and regulation concerns.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

STIM1 is essential for sweat secretion.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

3D cultivation and prenatal stem cell exosomes improve stem cell treatment results, especially for hair loss and age-related issues.

The drug combination was safe and showed promise in treating advanced tumors.

STAR particles are safe, comfortable, and effective for enhancing drug delivery through the skin.

The new drug delivery system effectively targets lung cancer cells.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Advancements in skin treatment and wound healing include promising gene therapy, 3D skin models, and potential new therapies.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Stauntonia hexaphylla leaves and fruits, especially leaves, may help prevent osteoporosis by boosting bone growth and reducing bone loss.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

VSELs may hold the key to longer life through regenerative therapies.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Improving mesenchymal stromal cell therapies requires overcoming cell death and optimizing delivery methods.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

A new compound shows promise as a topical treatment for hair loss.

The document concludes that stem cell therapies lack solid proof of effectiveness, except for blood system treatments, and criticizes the ethical issues and commercial exploitation in the field.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

Exosome-based therapies in dermatology show promise but face challenges in standardization, regulation, and safety.

Adding a second method to PROTACs could improve cancer treatment.